financetom
Business
financetom
/
Business
/
Independent Bank Insider Sold Shares Worth $3,497,110, According to a Recent SEC Filing
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Independent Bank Insider Sold Shares Worth $3,497,110, According to a Recent SEC Filing
Sep 11, 2025 1:36 PM

04:08 PM EDT, 09/11/2025 (MT Newswires) -- Ken S Ansin, Director, on September 09, 2025, sold 50,000 shares in Independent Bank (INDB) for $3,497,110. Following the Form 4 filing with the SEC, Ansin has control over a total of 596,752 common shares of the company, with 5,095 shares held directly and 591,657 controlled indirectly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/776901/000128275925000004/xslF345X05/wk-form4_1757621055.xml

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Mayfair Gold Q2 Loss Narrows
Mayfair Gold Q2 Loss Narrows
Aug 26, 2025
08:38 AM EDT, 08/26/2025 (MT Newswires) -- Mayfair Gold ( MFGCF ) after the close of trading on Monday reported a narrower loss in the second quarter. For the three-months ended June 30, the loss and comprehensive loss fell to $2.1 million or $0.02 loss per basic and diluted share, compared with $5.7 million or $0.06 per share, a year...
Genmab Says FDA Grants Breakthrough Designation to Rinatabart Sesutecan for Advanced Endometrial Cancer
Genmab Says FDA Grants Breakthrough Designation to Rinatabart Sesutecan for Advanced Endometrial Cancer
Aug 26, 2025
08:37 AM EDT, 08/26/2025 (MT Newswires) -- Genmab ( GMAB ) said Tuesday that its investigational drug rinatabart sesutecan, or Rina-S, has been granted Breakthrough Therapy Designation by the US Food and Drug Administration for the treatment of adults with recurrent or progressive endometrial cancer that has advanced after prior treatment with platinum chemotherapy and a PD-(L)1 therapy. The FDA's...
FTC Solar Signs Agreement With Levona Renewables for Solar Projects
FTC Solar Signs Agreement With Levona Renewables for Solar Projects
Aug 26, 2025
08:35 AM EDT, 08/26/2025 (MT Newswires) -- FTC Solar ( FTCI ) has signed an agreement with Levona Renewables to supply trackers and software for one gigawatt of solar projects from early 2026, the companies said Tuesday. The companies said that the first project under the agreement, CT Solar One, is a 140-megawatt solar facility currently under development in Texas....
ZenaTech Signs Offer to Buy UK Telecommunications Services Provider
ZenaTech Signs Offer to Buy UK Telecommunications Services Provider
Aug 26, 2025
08:37 AM EDT, 08/26/2025 (MT Newswires) -- ZenaTech ( ZENA ) said Tuesday it has signed an offer to acquire a UK-based 3D design and modeling company serving the telecommunications sector. Financial terms were not disclosed. The potential acquisition provides transmission tower design, upgrade, and inspection services, ZenaTech ( ZENA ) said. The acquisition would mark ZenaTech's ( ZENA )...
Copyright 2023-2026 - www.financetom.com All Rights Reserved